Bioptik Technology (ROCO:4161) ROCE % : 14.66% (As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Bioptik Technology ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Bioptik Technology's annualized ROCE % for the quarter that ended in Dec. 2024 was 14.66%.

Bioptik Technology ROCE % Historical Data

The historical data trend for Bioptik Technology's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioptik Technology ROCE % Chart

Bioptik Technology Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

-5.32

2.87

7.95

12.51

11.82

Bioptik Technology Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															19.13	9.94	13.18	9.77	14.66

Bioptik Technology ROCE % Calculation

Bioptik Technology's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	119.453	/	( ( (1497.706 - 516.762)	+	(1487.743 - 448.262) )	/ 2 )
	=	119.453	/	( (980.944	+	1039.481)	/ 2 )
	=	119.453	/	1010.2125
	=	11.82 %

Bioptik Technology's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	150.484	/	( ( (1496.394 - 482.288)	+	(1487.743 - 448.262) )	/ 2 )
	=	150.484	/	( ( 1014.106	+	1039.481 )	/ 2 )
	=	150.484	/	1026.7935
	=	14.66 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Bioptik Technology (ROCO:4161) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Bioptik Technology ROCE % Related Terms

Thank you for viewing the detailed overview of Bioptik Technology's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioptik Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bioptik Technology Inc (ROCO:4161) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.188, Zhonghua South Road, Miaoli County, Zhunan, TWN, 35057

Website

http://www.bioptik.com.tw

Bioptik Technology Inc is a Taiwan-based company engaged in the research, development, production, and sale of medical devices and reagents. The company is also focused on developing skin care products and aims to engage in developing bioenergy, Astaxanthin, and Cellulose Bioethanol. It is involved in the business areas of Home care medical devices, Skincare- Its own brand, Dietary supplement OEM and ODM, Skincare- OEM and ODM, and Biodiesel. In the Home care business area, the company provides Easy Touch blood glucose monitoring, and blood cholesterol and uric acid monitoring systems, as well as its strips.

Bioptik Technology Headlines

No Headlines